HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GS 101

an antisense oligonucleotide that prevents expression of insulin receptor substrate-1; base sequence in first source
Also Known As:
GS-101; GS101 antisense oligonucleotide; aganirsen
Networked: 8 relevant articles (1 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cursiefen, Claus: 5 articles (09/2014 - 09/2009)
2. Colin, Sylvie: 4 articles (09/2014 - 05/2009)
3. Bock, Felix: 3 articles (09/2014 - 09/2009)
4. Ferry, Antoine: 3 articles (09/2014 - 03/2012)
5. Thorin, Eric: 3 articles (09/2014 - 05/2009)
6. Al-Mahmood, Salman: 3 articles (04/2014 - 05/2009)
7. Geudelin, Bernard: 2 articles (09/2014 - 09/2009)
8. Meller, Daniel: 2 articles (09/2014 - 09/2009)
9. Seitz, Berthold: 2 articles (09/2014 - 09/2009)
10. Viaud, Eric: 2 articles (09/2014 - 03/2012)

Related Diseases

1. Retinal Neovascularization
2. Corneal Neovascularization
3. Keratitis
4. Psoriasis (Pustulosis Palmaris et Plantaris)
5. Choroidal Neovascularization

Related Drugs and Biologics

1. Antisense Oligonucleotides
2. Ophthalmic Solutions (Eye Drops)
3. Insulin Receptor Substrate Proteins
4. GS 101
5. Messenger RNA (mRNA)
6. Insulin Receptor
7. Proteins (Proteins, Gene)
8. Oxygen (Dioxygen)
9. Ranibizumab (Lucentis)
10. Bevacizumab (Avastin)

Related Therapies and Procedures

1. Therapeutics
2. Transplantation
3. Intravitreal Injections
4. Sutures (Suture)
5. Lasers (Laser)